Sweden, Denmark pause Moderna vaccine for younger age groups

Sweden, Denmark pause Moderna vaccine for younger age groups

by Joseph Anthony
175 views

The Swedish health agency said it would pause using the shot for people born in 1991 and later

Sweden and Denmark said on Wednesday they are pausing the use of Modernaโ€™s COVID-19 vaccine for younger age groups after reports of possible rare side effects.

The Swedish health agency said it would pause using the shot for people born in 1991 and later as data pointed to an increase of myocarditis and pericarditis among youths and young adults that had been vaccinated. Those conditions involve an inflammation of the heart or its lining.
โ€œThe connection is especially clear when it comes to Modernaโ€™s vaccine Spikevax, especially after the second dose,โ€ the health agency said, adding the risk of being affected was very small.
Denmark said that, while it used the Pfizer/BioNTech vaccine as its main option for people aged 12-17 years, it had decided to pause giving the Moderna vaccine to people below 18 according to a โ€œprecautionary principleโ€.
โ€œIn the preliminary data โ€ฆ there is a suspicion of an increased risk of heart inflammation, when vaccinated with Moderna,โ€ the Danish Health Authority said in a statement.
It referred to data from a yet unpublished Nordic study, which would now be sent to the European Medicines Agency (EMA) for further assessment. Final data was expected within a month, it added.
Sweden and Denmark said they now recommended the Comirnaty vaccine, from Pfizer/BioNTech,, instead.
The Danish Health Authority said it had made the decision even as โ€œheart inflammation is an extremely rare side effect that often has a mild course and goes away on its ownโ€.
The EMAโ€™s safety committee concluded in July that inflammatory heart conditions can occur in very rare cases following vaccination with Comirnaty or Spikevax, more often in younger men after the second dose.
The benefits of shots based on so-called mRNA technology used by both Moderna and Pfizer-BioNTech in preventing COVID-19 continue to outweigh the risks, regulators in the United States, EU and the World Health Organization have said.
Data suggests reported cases of rare heart inflammation are relatively higher after Modernaโ€™s vaccine compared with the Pfizer/BioNTech shots, Canadian health officials said last week.
Norway already recommends the Cominarty vaccine to minors and said on Wednesday that it was reiterating this.
โ€œMen under the age of 30 should also consider choosing Cominarty when they get vaccinated,โ€ Geir Bukholm, head of infection control at the Norwegian Institute of Publica Health, said in a statement.
A Finnish health official said Finland expected to publish a decision on Thursday.
The EMA approved the use of Comirnaty in May, while Spikevax was given the nod for children over 12 in July.
REUTERS

You may also like

Leave a Comment

Chijos News is an independent online publication that provides readers with the latest breaking Nigerian news, world news, entertainment, sports, business, and many more.

@2024 – Chijosnews.com. All Rights Reserved.

-
00:00
00:00
Update Required Flash plugin
-
00:00
00:00